Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 7, 2002, Pages 641-646

  Horsti, Juha ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

International Normalized Ratio; International Sensitivity Index; Prothrombin time

Indexed keywords

FIBRINOGEN; PROTHROMBIN; REAGENT; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANALYTICAL ERROR; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CALIBRATION; DIAGNOSTIC ACCURACY; HEMATOLOGICAL PARAMETERS; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; INTERNATIONAL NORMALIZED RATIO; REPRODUCIBILITY;

CALIBRATION; HUMANS; INDICATORS AND REAGENTS; INTERNATIONAL NORMALIZED RATIO; PROTHROMBIN TIME; REPRODUCIBILITY OF RESULTS;

EID: 0036775175     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200210000-00010     Document Type: Article

References (30)

1. Palareti G, Leali N, Coccheri S, Coccheri S, Poggi M, Manotti C, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-428.
2. International Committee for Standardisation in Haematology. International Committee on Thrombosis and Haemostastis. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 1985; 53: 155-156.
3. WHO Expert Committee on Biological Standardisation. Thirty-third Report. Technical Report Series 687. Geneva: World Health Organisation; 1983. pp. 81-105.
4. Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on the calculation of the International Normalised Ratio and the International Sensitivity Index of thromboplastin. Thromb Haemost 1994; 72: 84-88.
5. Horsti J. Preanalytical aspects of routine coagulation measurements. Scand J Clin Lab Invest 2001; 61: 167-168.
6. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107: 105-110.
7. Chantarangkul V, Tripoldi A, Clerici M, Negri B, Mannucci PM. Assessment of the influence of citrate concentration on the International Normalised Ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 1998; 80: 258-262.
8. van den Besselaar AM. International Standardisation of Laboratory Control of Oral Anticoagulant Therapy: A survey of thromboplastin reagents used for prothrombin time testing. J Heart Valve Dis 1993; 2: 42-52.
9. Cunningham MT, Johnson GF, Pennell BJ, Olson JD. The reliability of manufacturer-determined, instrument-specific international sensitivity index values for calculating the international normalised ratio. Am J Clin Pathol 1994; 102: 128-133.
10. van Rijn JL, Schmidt NA, Rutten WP. Correction of instrument-and reagent-based differences in determination of the International Normalised Ratio (INR) for monitoring anticoagulant therapy. Clin Chem 1989; 35: 840-843.
11. Ng VL, Levin J, Corash L, Gottfried EL. Failure of the International Normalised Ratio to generate consistent results within a local medical community. Am J Clin Pathol 1993; 99: 689-694.
12. Talstad I. Why is the standardisation of prothrombin time a problem? Haemostasis 2000; 30: 258-267.
13. Poller L, van den Besselaar AM, Jespersen J, Tripodi A, Houghton D. A comparison of linear and orthogonal regression analysis for local INR determination in ECAA coagulometer studies. Br J Haematol 1998; 102: 910-917.
14. Kirkwood TB. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983; 49: 238-244.
15. Hermans J, van den Besselaar AM, Loeliger EA, van der Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemost 1983; 50: 712-717.
16. Craig S, Stevenson KJ, Dufty JM, Taberner DA. Local INR correction: Justification for a simplified approach. J Clin Pathol 1997; 50: 783-789.
17. Stevenson KJ, Craig S, Dufty JM, Taberner DA. System ISI calibration: A universally applicable scheme is possible only when coumarin plasma calibrants are used. Br J Haematol 1997; 96: 435-441.
18. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998; 114: 445-469.
19. Kjeldsen J, Lassen JF, Petersen PH, Brandslund I. Biological variation of International Normalised Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: Computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem 1997; 43: 2175-2182.
20. Lassen JF, Brandslund I, Antonsen S. Determination of critical difference and probability of significant change in consecutive measurements of International Normalised Ratio (INR) from patients on oral anticoagulant therapy. Clin Chem 1995; 41: 444-447.
21. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935; 190: 501-511.
22. Quick AJ. The prothrombin time in haemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73-74.
23. Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959; 2: 754-758.
24. Horsti J. Agreement of Owren and Quick prothrombin times: Effects of citrate and calcium concentrations and International Sensitivity Index correction. Clin Chem 2001; 47: 940-944.
25. Horsti J. Measurement of prothrombin time in EDTA plasma with combined thromboplastin reagent. Clin Chem 2000; 46: 1844-1846.
26. Horsti J. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants. Haematologica 2001; 86: 851-855.
27. Horsti J. EDTA samples are stable for prothrombin time measurement by combined thromboplastin reagent. Clin Chem 2001; 47: 1731-1733.
28. Horsti J. Comparison of Quick and Owren prothrombin time with regard to the harmonisation of the International Normalised Ratio (INR) system. Clin Chem Lab Med 2002; 40: 399-403.
29. Introcaso G, Cuboni A, Ratto A, Foieni F. Mathematical derivative applied to International Normalised Ratio and analytical variations in oral anticoagulant therapy control. Haemostasis 2000; 30: 281-289.
30. Van den Besselaar AM, Houbouyan-Reveillard LL, Aillaud MF, Denson KW, Droulle C, Johnston M, et al. Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalised Ratio. Thromb Haemost 1999; 82: 1451-1455.